Fitzgerald Kevin Joseph (CIK 0001886431)

Latest company ownership

ALNY - ALNYLAM PHARMACEUTICALS, INC.

Role: CSO & EVP, Head of Research

Shares held

537

Last filed at

Nov 19, 2025

Confidence Score

64.5

2025Q4

Confidence Score History

2024Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 17, 2025	Nov 19, 2025	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	Sell	3.8	-12,128	-35.75%	✓	$5.5M
Oct 1, 2025	Oct 3, 2025	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	Sell	100.0	+2,512	10.80%	✗	$1.1M
Aug 15, 2025	Aug 19, 2025	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	Sell	92.5	+1,455	6.67%	✗	$632.8K
Mar 3, 2025	Mar 5, 2025	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	Sell	92.5	+1,116	8.64%	✓	$669.3K
Feb 28, 2025	Mar 3, 2025	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	Sell	42.5	-496	-3.70%	✗	$119.9K
Feb 13, 2025	Feb 18, 2025	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	Sell	51.3	-	0.00%	✓	$531.4K
Nov 25, 2024	Nov 27, 2024	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	Sell	51.3	-	0.00%	✓	$754.9K
Aug 12, 2024	Aug 14, 2024	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	Sell	3.8	-22,025	-62.14%	✓	$6M
Jun 24, 2024	Jun 26, 2024	ALNYLAM PHARMACEUTICALS, INC.	CSO & EVP, Head of Research	Sell	92.5	+1,300	9.69%	✗	$276.7K